[Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms].
The aim of our study was to evaluate the usefulness of the tumor markers CA 72.4, CEA and CA 19.9 in the monitoring of gastrointestinal carcinomas. Our experience demonstrated the usefulness of the determination of CA 72.4 in the follow up of patients with gastrointestinal neoplasms.
Marchei
P
P
Dipartimento di Medicina Sperimentale, Università degli Studi La Sapienza, Roma.
Cifaldi
L
L
De Benedetto
A
A
Santini
D
D
Manna
A
A
Trasatti
L
L
Marchei
G G
GG
Reale
M G
MG
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D004067:Digestive System Neoplasms / Q000097:blood*; D005500:Follow-Up Studies; D006801:Humans
D015295:Antigens, Tumor-Associated, Carbohydrate; D002272:Carcinoembryonic Antigen
Valutazione clinica dell'efficacia dell'associazione dei markers sierici CEA, CA 19.9, CA 72.4 come indici di neoplasia del tratto gastro-intestinale.